𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Troglitazone inhibits synthesis of transforming growth factor-β1 and reduces matrix production in human peritoneal mesothelial cells

✍ Scribed by YOUMING PENG; HONG LIU; FUYOU LIU; YINGHONG LIU; JUN LI; XING CHEN

Book ID
108960209
Publisher
John Wiley and Sons
Year
2006
Tongue
English
Weight
240 KB
Volume
11
Category
Article
ISSN
1320-5358

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

N-[3,4-dimethoxycinnamoyl]-anthranilic a
N-[3,4-dimethoxycinnamoyl]-anthranilic acid (tranilast) inhibits transforming growth factor-β release and reduces migration and invasiveness of human malignant glioma cells
✍ Michael Platten; Christine Wild-Bode; Wolfgang Wick; Jens Leitlein; Johannes Dic 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 French ⚖ 335 KB

Extensive infiltration of normal brain tissue and suppression of anti-tumor immune surveillance mediated by molecules such as transforming growth factor-␤ (TGF-␤) are key biological features that contribute to the malignant phenotype of human gliomas. Tranilast (N-[3,4-dimethoxycinnamoyl]-anthranili

Multidrug transport in human glioblastom
Multidrug transport in human glioblastoma cells is inhibited by transforming growth factors type β1, β2, and β1.2
✍ Ph.D. H. J. Schluesener 📂 Article 📅 1991 🏛 John Wiley and Sons 🌐 English ⚖ 377 KB 👁 1 views

The transforming growth factors type PI, p2, and p,.2 suppress multidrug transport in human pat-1 glioblastoma cells and even in cells that strongly overexpress mdr genes and are resistant to inhibition of multidrug transport by chemosensitizers. Thus, inhibition of multidrug transport by cytokines

Transforming growth factor β1 (TGF-β1) i
Transforming growth factor β1 (TGF-β1) inhibits growth of a human ovarian carcinoma cell line (OVCCR1) and is expressed in human ovarian tumors
✍ S. Jozan; M. Guerrin; P. Mazars; M. Dutaur; B. Monsarrat; F. Cheutin; R. Bugat; 📂 Article 📅 1992 🏛 John Wiley and Sons 🌐 French ⚖ 957 KB

## Abstract The effects of EGF and TGF‐β1 on the proliferation of 2 ovarian carcinoma cell lines (IGROV1 and OVCCR1) were evaluated. The cell lines were adapted to grow in a restricted serum (0.5%) medium. EGF was required for proliferation of both ovarian cell lines. Low doses of TGF‐β1 inhibited